close_game
close_game
[

indian council

]

Latest from indian council

Vaccines bring greater hope

But Bharat Biotech and regulators must now speed up disclosures on Covaxin

A medic fills a syringe with Covaxin, an Indian government-backed experimental Covid-19 vaccine, before administering it to a health worker during its trials, at the Gujarat Medical Education and Research Society, Ahmedabad, November 26, 2020(REUTERS)
Updated on Jan 04, 2021 11:10 AM IST

Pune hospitals find plasma therapy effective in moderate Covid-19 patients

ICMR study has found that this therapy is not as promising in bringing down the mortality rate

A health worker takes test tubes with plasma and blood samples after a separation process in a centrifuge during a coronavirus disease (COVID-19) vaccination study at the Research Centers of America.(REUTERS)
Updated on Oct 26, 2020 03:27 PM IST
Hindustan Times, Pune | BySteffy Thevar

No Oxford vaccine side effects in 53 volunteers at PGIMER

PGIMER had screened 97 volunteers on Thursday, of whom 65 had already been vaccinated since September 25 when the institute started administering the first dose to volunteers

PGIMER is expected to administer the vaccine to around 300 volunteers in phase 2 and 3 of the observer-blind, randomised, controlled study to determine the safety of Covishield (Covid-19 vaccine) and its immunogenicity (ability to provoke immune response) in healthy Indian adults.(REUTERS/For representation)
Updated on Oct 08, 2020 11:45 PM IST
Hindustan Times, Chandigarh | ByHT Correspondent, Chandigarh

HP University offers direct admission in PhD programmes

The last date of submission of forms is October 3, 2020

Himachal Pradesh University is inviting applications for PhD programmes.(HT Photo)
Updated on Sep 22, 2020 04:54 PM IST
Hindustan Times, Shimla | By, Shimla

Rohtak’s PGIMS begins second phase of clinical trials for indigenous Covid vaccine, Covaxin

12 volunteers administered dose of vaccine through intramuscular injection, next dose after 28 days

Covaxin, which has been developed in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), will be tested on 50 volunteers at Post Graduate Institute of Medical Sciences, Rohtak, in Phase 2.(Reuters file photo)
Published on Sep 10, 2020 02:14 AM IST
Hindustan Times, Rohtak | ByHT Correspondent
Story Saved
Live Score
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Wednesday, March 26, 2025
Start 14 Days Free Trial Subscribe Now
Follow Us On